...
首页> 外文期刊>Angewandte Chemie >A Formal Total Synthesis of Eleutherobin Through an Unprecedented Kinetically Controlled Ring-Closing-Metathesis Reaction of a Densely Functionalized Diene
【24h】

A Formal Total Synthesis of Eleutherobin Through an Unprecedented Kinetically Controlled Ring-Closing-Metathesis Reaction of a Densely Functionalized Diene

机译:通过空前的动力学控制的闭环复分解反应的功能强大的二烯的形式的全合成大黄素。

获取原文
获取原文并翻译 | 示例
           

摘要

Sarcodictyins A (1 a) and B (1 b) were isolated in 1987 by Pietra and co-workers from the Mediterranean stoloniferan coral Sarcodictyon roseum.[1] Their antitumor activity was recognized about a decade later, and their taxol-like mechanism of action was discovered in 1996.[2] In the meantime, the diterpene glycoside eleutherobin (2) was reported by Fenical et al. from an Eleutherobia species of Australian soft coral, accompanied by disclosure of its potent cytotoxicity in 1995.[3] Two years later, eleutherobin was shown to act similarly to the sarcodictyins, effecting mitotic arrest through tubulin polymerization.[4] Both sarcodictyins and eleutherobin (the eleutheside family of microtubule-stabilizing drugs) are characterized by an activity profile different from that of taxol; they are active against taxol-resistant tumor cell lines and therefore hold potential as second-generation microtubule-stabilizing anticancer agents.[4], [5] The scarce availability of 1 and 2 from natural sources makes their total syntheses vital for further biological investigations.[5] To date, sarcodictyin A and B have been synthesized successfully by Nicolaou et al.,[6] who have also exploited a similar route to eleutherobin.[7] A subsequent report by Danishefsky and co-workers details an elegant alternative access to eleutherobin.[8] A number of synthetic approaches to the eleutheside natural products and syntheses of simplified analogues have also been described.
机译:Pieco及其同事于1987年从地中海柏珊瑚珊瑚Sarcodictyon roseum中分离出Sarcodictyins A(1a)和B(1b)[1]。大约十年后,他们的抗肿瘤活性得到认可,1996年发现了类似紫杉醇的作用机制。[2]同时,Fenical等报道了二萜糖苷eleutherobin(2)。取自澳大利亚软珊瑚的一种大肠埃希菌,并在1995年发现了其潜在的细胞毒性。[3]两年后,显示eleutherobin的作用类似于sarcodictyins,通过微管蛋白聚合作用实现有丝分裂阻滞。[4]石co素和eleutherobin(微管稳定药物的伊卢赛德家族)的特征均不同于紫杉醇。它们对紫杉醇抗性肿瘤细胞系具有活性,因此具有作为第二代稳定微管的抗癌药的潜力。[4],[5]天然来源的1和2稀缺,因此其总合成对于进一步的生物学研究至关重要。[5]迄今为止,Nicolaou等人[6]已成功合成了肌果糖蛋白A和B,他们也采用了类似的途径来合成丝氨酸。[7] Danishefsky及其同事随后发表的一份报告详细介绍了一种精细的替代途径,以获取细铁蛋白。[8]还已经描述了许多关于叶黄素天然产物的合成方法和简化类似物的合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号